Inhibition of ABCB1 (MDR1) and ABCB4 (MDR3) expression by small interfering RNA and reversal of paclitaxel resistance in human ovarian cancer cells.
about
Different Facets of Copy Number Changes: Permanent, Transient, and AdaptiveInsulin-like growth factor 2 silencing restores taxol sensitivity in drug resistant ovarian cancerCommon variants in ABCB1, ABCC2 and ABCG2 genes and clinical outcomes among women with advanced stage ovarian cancer treated with platinum and taxane-based chemotherapy: a Gynecologic Oncology Group study.Inhibition of ABCB1 (MDR1) expression by an siRNA nanoparticulate delivery system to overcome drug resistance in osteosarcomaAssociation of drug transporter expression with mortality and progression-free survival in stage IV head and neck squamous cell carcinomaOvarian cancer side population defines cells with stem cell-like characteristics and Mullerian Inhibiting Substance responsivenessThe siRNA targeted to mdr1b and mdr1a mRNAs in vivo sensitizes murine lymphosarcoma to chemotherapyGlucose-dependent regulation of pregnane X receptor is modulated by AMP-activated protein kinase.Side population cells from human melanoma tumors reveal diverse mechanisms for chemoresistance.Chemotherapy-induced hyaluronan production: a novel chemoresistance mechanism in ovarian cancer.MDR1 siRNA loaded hyaluronic acid-based CD44 targeted nanoparticle systems circumvent paclitaxel resistance in ovarian cancer.A genistein derivative, ITB-301, induces microtubule depolymerization and mitotic arrest in multidrug-resistant ovarian cancer.Evaluation of stem-like side population cells in a recurrent nasopharyngeal carcinoma cell line.Cluster of Differentiation 44 Targeted Hyaluronic Acid Based Nanoparticles for MDR1 siRNA Delivery to Overcome Drug Resistance in Ovarian Cancer.A stress-induced early innate response causes multidrug tolerance in melanoma.Up-regulation of CD44 in the development of metastasis, recurrence and drug resistance of ovarian cancer.Optimizing molecular-targeted therapies in ovarian cancer: the renewed surge of interest in ovarian cancer biomarkers and cell signaling pathways.SULF2 methylation is prognostic for lung cancer survival and increases sensitivity to topoisomerase-I inhibitors via induction of ISG15.Reversal of Chemoresistance in Ovarian Cancer by Co-Delivery of a P-Glycoprotein Inhibitor and Paclitaxel in a Liposomal Platform.Lipid-functionalized dextran nanosystems to overcome multidrug resistance in cancer: a pilot studyLentiviral short hairpin RNA screen of genes associated with multidrug resistance identifies PRP-4 as a new regulator of chemoresistance in human ovarian cancer.Reversal of ABC drug transporter-mediated multidrug resistance in cancer cells: evaluation of current strategies.A leukotriene B4 receptor-2 is associated with paclitaxel resistance in MCF-7/DOX breast cancer cellsHistone deacetylase inhibitor PCI-24781 enhances chemotherapy-induced apoptosis in multidrug-resistant sarcoma cell lines.Improved anti-tumor therapy based upon infectivity-enhanced adenoviral delivery of RNA interference in ovarian carcinoma cell lines.The Role of Eukaryotic and Prokaryotic ABC Transporter Family in Failure of Chemotherapy.TP53 hot spot mutations in ovarian cancer: selective resistance to microtubule stabilizers in vitro and differential survival outcomes from The Cancer Genome Atlas.Antiproliferative efficacies but minor drug transporter inducing effects of paclitaxel, cisplatin, or 5-fluorouracil in a murine xenograft model for head and neck squamous cell carcinoma.Multidrug resistance transporter profile reveals MDR3 as a marker for stratification of blastemal Wilms tumour patients.Nanomedicinal strategies to treat multidrug-resistant tumors: current progress.Molecular mechanisms for biliary phospholipid and drug efflux mediated by ABCB4 and bile saltsMDR1 mediated chemoresistance: BMI1 and TIP60 in actionDown-regulation of Bcl-XL by RNA interference suppresses cell growth and induces apoptosis in human esophageal cancer cells.New approaches for cancer treatment: antitumor drugs based on gene-targeted nucleic acids.
P2860
Q26769649-2539C5F0-FA00-4476-BD1B-6BCF788CDF48Q27322873-D339B601-6F8E-4C44-9A37-0E59A53B6EC5Q27851688-8C353492-2797-489D-A941-442C0434868FQ28474030-B52C9929-7A7A-4162-A451-DFB57C753D86Q28543497-B34E9009-5241-4311-9A15-7055C9FD097CQ33250633-2A22C22B-F318-4BAA-966B-0640608A1CB3Q33578222-B67CCC70-9FE9-4E16-8DF8-1C6989791B8AQ33594309-2E094D10-2ED8-4EFE-8231-0279A58D506EQ34279342-794C5C5A-C691-404E-97FB-1A11645BC163Q35017209-0DABA3C6-15CE-4541-8473-9E8DE8F53371Q35089472-539B82FC-D09E-4340-A8A3-9C78D3B8F687Q35233555-D63907F7-C784-4DE1-BE69-F89F9A1FC184Q35333542-D4ADA428-F898-45D1-8515-D644B0D561C8Q35587385-62399B17-6506-4F62-AD44-8A11D1CFDA5EQ35639898-56FE8D3D-DBE9-47FA-99DA-CDB9C0725482Q35832351-7E177013-7040-4F13-979B-FE362072A55FQ35837949-726D0C24-0D2C-431E-B6E7-92491781DB28Q35840419-7B2DCA6A-6BB4-4643-AF83-D66976730E45Q36088140-B8D2C8D8-790D-4CC9-A433-25383B3772B2Q36585890-983A716E-7412-4115-B749-CCFC9BB8EB01Q37003211-91967BFD-EFAE-4618-ADF9-C56AEFDF6BD4Q37010772-38C96CE0-104B-4F3B-BDAA-F2A986B619AFQ37040640-130F575C-2165-4AAF-A82F-D8E261455CFFQ37097022-552E936B-9485-4C14-84BE-7FEDCA6939A6Q37347835-F932A9D5-239D-4641-9C12-847BC5355D63Q37576360-F40CF2D9-0029-4095-AC42-D8E0F0FA22F3Q37636824-B63503E5-D27E-42EB-B292-5759EBA8A92BQ37692463-B6DE687C-189A-4785-9088-D6F7086C2095Q37706888-A1B68F31-AB49-4664-80E4-EBC6AA1997A0Q37763152-D965B634-4678-44E4-B559-F989FDCB532EQ38240898-22F993BF-4CA2-4495-A090-BBA8A63678D2Q39687663-D17F36D2-02FB-49B4-BB4B-5A4EE8A83954Q40196674-8550FAB0-670A-46BF-891E-3F1C7B147857Q42153007-E56EB162-9E1B-43E4-8C49-3B6E6A46C942
P2860
Inhibition of ABCB1 (MDR1) and ABCB4 (MDR3) expression by small interfering RNA and reversal of paclitaxel resistance in human ovarian cancer cells.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Inhibition of ABCB1 (MDR1) and ...... in human ovarian cancer cells.
@en
type
label
Inhibition of ABCB1 (MDR1) and ...... in human ovarian cancer cells.
@en
prefLabel
Inhibition of ABCB1 (MDR1) and ...... in human ovarian cancer cells.
@en
P2093
P1476
Inhibition of ABCB1 (MDR1) and ...... in human ovarian cancer cells
@en
P2093
Katherine A Brakora
Michael V Seiden
Zhenfeng Duan
P304
P577
2004-07-01T00:00:00Z